GGrantIndex
Sort

89,613 grants matching depression

2/7 PsycheMERGE: Advancing Precision Psychiatry

$831,180
Jordan W Smoller · Massachusetts General Hospital · R01 · FY2024 · MH

Sleep to Reduce Incident Depression Effectively in Peripartum - (STRIDE P)

$831,140
Christopher L Drake · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · MH

Prospective studies on Parkinson's disease

$830,575
Honglei Chen · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

Mental health and chronic disease: A psycheMERGE investigation into the shared biology underlying psychiatric disorders and their physical comorbidities

$830,559
Lea K Davis · Vanderbilt University Medical Center · R56 · FY2019 · MH

Group II mGluR antagonists and negative modulators in depression

$830,492
Athina Markou · University Of California, San Diego · R01 · FY2013 · MH

Precision TMS with integrated visualization and analysis of real-time E-field and EEG source imaging

$830,409
Lipeng Ning · Brigham And Women'S Hospital · R01 · FY2025 · MH

Operation Core-ACISR for Late-Life Depression Prevention

$830,333
Charles F Reynolds · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · MH

Integrative Genomics of the Corticolimbic Circuit in Major Depressive Disorder

$830,273
Fernando Sampaio Goes · Johns Hopkins University · R01 · FY2020 · MH

Inhibition of central CO2 chemoreception by seizures: Effects on ventilation, cardiovascular control and postictal recovery of consciousness

$830,258
George B Richerson · University Of Iowa · R01 · FY2024 · NS

Social Cognition and Suicide in Psychotic Disorders

$830,170
Colin A Depp · University Of California, San Diego · R01 · FY2022 · MH

RFA-DP-24-031: Longitudinal Follow-up of a Nationwide Multiethnic Cohort of Veterans and Non-Veterans with Interstitial Cystitis

$830,000
Jennifer Tash Anger · University Of California, San Diego · U01 · FY2025 · DP

Community processes structuring assembly and disassembly of bat gut-microbial communities across a gradient of habitat degradation

$829,959
Tigga Kingston · Texas Tech University · · FY2018 · BIO

Recombinant Interleukin-12 for Cutaneous T-Cell Lymphoma

$829,822
University Of Pennsylvania · R01 · FY2004 · CA

MONEAD Data and Statistical Center

$829,735
Nancy Browning · The Emmes Company, Llc · U01 · FY2012 · NS

Neural mechanisms of reward processing and emotion

$829,678
Elisabeth A Murray · National Institute Of Mental Health · ZIA · FY2019 · MH

Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral Influences

$829,667
Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2014 · CA

Understanding Patient, Provider, and Systems Stakeholder Attitudes and Preferences to Optimize Implementation of Long-Acting Injectable Antiretrovirals and Maximize Clinical and Public Health Impact

$829,528
Katerina A Christopoulos · University Of California, San Francisco · R01 · FY2020 · MH

A Randomized Trial of Physical Activity for Cognitive Functioning in Breast Cancer Survivors

$829,364
Sheri J Hartman · University Of California, San Diego · R01 · FY2023 · CA

Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children (ENRICH)

$829,350
Janet M Catov · Magee-Women'S Res Inst And Foundation · UH3 · FY2024 · HL

Optimizing a self-directed mobile mindfulness intervention for improving

$829,342
Christopher Ethan Cox · Duke University · U01 · FY2018 · AT

Development of Selective Inhibitors of NaV1.7 as Therapeutics for Pain

$829,314
John Vincent Mulcahy · Siteone Therapeutics, Inc. · R44 · FY2017 · NS

Epidemiological analysis of two interstitial cystitis cohorts

$829,242
Catherine Astrid Brownstein · Boston Children'S Hospital · U01 · FY2022 · DP

Epidemiological analysis of two interstitial cystitis cohorts

$829,242
Catherine Astrid Brownstein · Boston Children'S Hospital · U01 · FY2021 · DP

Epidemiological analysis of two interstitial cystitis cohorts

$829,242
Catherine Astrid Brownstein · Boston Children'S Hospital · U01 · FY2023 · DP

Understanding Vision Impairment in ESKD to Prevent Cognitive Impairment and Dementia/Alzheimer’s disease: the VIS-HD Cohort Study

$829,211
Mara A. McAdams Demarco · New York University School Of Medicine · R01 · FY2025 · AG